Alzheimer's disease, a devastating neurodegenerative condition that impacts millions globally, may have found an unexpected ...

McLaughlin joined the Lepodisiran trial, but she doesn’t know whether she got the drug or a placebo. She also has another condition that predisposes her to high LDL cholesterol called familial ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

A family history of early heart disease, chronic kidney disease, and other factors may also play into the decision to start on cholesterol-lowering medication. If the risk decision remains ...